FCGR2B and autoimmune disease: Only pan-myeloid deletion (cEBPαCre) of FcγRIIb increased the susceptibility of LeFcγRIIbB6fl/fl mice for CIA on the permissive background (187) and for the non-autoimmune disease NTN (89).